We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current TWST market cap is 2.17B. The company's latest EPS is USD -3.4926 and P/E is -10.55.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 64.32M | 66.95M | 71.5M | 75.3M | 81.46M |
| Operating Income | -57.16M | -53.73M | -46.98M | -48.89M | -88.92M |
| Net Income | -57.4M | -46.24M | -43.01M | -45.49M | -85.57M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 54.39M | 90.1M | 132.87M | 217.81M | 251.02M |
| Operating Income | -108.85M | -139.88M | -152.73M | -234.78M | -217.16M |
| Net Income | -107.67M | -139.73M | -152.1M | -217.86M | -204.62M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 810.33M | 776.4M | 732.82M | 702.85M | 638.12M |
| Total Liabilities | 152.78M | 152.97M | 142.77M | 142.72M | 146.98M |
| Total Equity | 657.55M | 623.43M | 590.04M | 560.13M | 491.14M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 186.99M | 398.88M | 702.1M | 961.38M | 776.4M |
| Total Liabilities | 34.91M | 62.62M | 121.28M | 171.99M | 152.97M |
| Total Equity | 152.08M | 336.26M | 580.82M | 789.39M | 623.43M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -121.77M | -142.47M | -22.97M | -42.4M | -48.77M |
| Investing | 52.86M | 50.61M | 4.17M | -1.08M | -1.79M |
| Financing | 469k | 911k | -1.47M | 355k | 3.26M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -87.94M | -142.26M | -112.24M | -124.39M | -142.47M |
| Investing | -104.81M | -114.65M | 156.16M | -232.93M | 50.61M |
| Financing | 158.58M | 303.73M | 329.18M | 270.53M | 911k |
| Market Cap | 2.17B |
| Price to Earnings Ratio | -10.55 |
| Price to Sales Ratio | 8.6 |
| Price to Cash Ratio | 7.54 |
| Price to Book Ratio | 3.46 |
| Dividend Yield | - |
| Shares Outstanding | 58.59M |
| Average Volume (1 week) | 940.63k |
| Average Volume (1 Month) | 683.3k |
| 52 Week Change | 88.10% |
| 52 Week High | 60.90 |
| 52 Week Low | 18.80 |
| Spread (Intraday) | 25 (41.67%) |
| Company Name | Twist Bioscience Corporation |
| Address |
3500 south dupont highway dover, delaware 19901 |
| Website | https://www.twistbioscience.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
